From the Journals

Obesity interactions complex in acute pancreatitis


 

FROM PANCREATOLOGY

Obesity’s complex interactions

Commenting on the study, Vijay P. Singh, MD, a professor of medicine in the division of gastroenterology and hepatology at the Mayo Clinic in Scottsdale, Ariz., agreed that the complexities risk factors, particularly with obesity, can be tricky to detangle.

“Broadly, the study confirms several previous reports from different parts of the world that obesity was associated with increased mortality in acute pancreatitis,” he said in an interview.

“However, obesity had two complex interactions, the first that obesity is also associated with increased diabetes, and hypertriglyceridemia, which may themselves be risk factors for severity,” he explained.

“The second one is that intermediary severity markers [e.g., Balthazar score on imaging] did not correlate with the BMI categories.”

Dr. Singh noted that is “likely because therapies like IV fluids that may get more intense in predicted severe disease alter the natural course of pancreatitis.”

The findings are a reminder that “BMI is only a number that attempts to quantify fat,” Dr. Singh said, noting that BMI doesn’t address either the location of fat, such as being in close proximity to the pancreas, or fat composition, such as the proportion of unsaturated fat.

“When the unsaturated fat proportion is higher, the pancreatitis is worse, even at smaller total fat amounts [for example, at a lower BMI],” he said. “Taking these aspects into account may help in risk assessment.”

The authors and Dr. Singh had no disclosures to report.

Pages

Recommended Reading

Obesity interventions tied to colon cancer risk reduction
MDedge Endocrinology
In diabetes, fast-growing pancreatic cysts may be a red flag
MDedge Endocrinology
Sleeve, RYGB reduce liver fat in type 2 diabetes
MDedge Endocrinology
Swallowable intragastric balloon shows significant weight loss
MDedge Endocrinology
Gut bacteria linked with long COVID
MDedge Endocrinology
Excess weight over lifetime hikes risk for colorectal cancer
MDedge Endocrinology
AHA statement addresses CVD risk in NAFLD
MDedge Endocrinology
Endoscopic obesity treatments offer alternatives to surgery
MDedge Endocrinology
‘Forever chemicals’ linked to liver damage
MDedge Endocrinology
Longer use of proton pump inhibitors tied to diabetes risk
MDedge Endocrinology